Pharmaniaga posts steady Q1 profit, to expand vaccine business as Covid-19 rages   

KUALA LUMPUR: Pharmaniaga Bhd said revenue from its Sinovac Covid-19 business to start coming in from the June quarter onwards.

"The distribution of the first batch of 290,480 doses of the vaccine to the market has commenced on May 11," the company said in a filing with Bursa Malaysia today.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Pharmaniaga , Sinovac , Vaccine

Next In Business News
WEF flags economic downturn, inflation, asset bubbles as key risks for Malaysia
Capital A disposes of 17 million AirAsia X shares for RM28.05mil
Sunview proposes private placement to raise RM19mil
AirAsia X says no decision yet on renaming to AirAsia on Jan 19
Atlan flags challenging 4Q26 as 3Q profit plunges
Focus Point joins Bursa Malaysia Quality indices
Ringgit rises 0.2% against US dollar at close
BHIC partners with French DCI to explore defence collaboration
TNB signs Energy Wheeling Agreement
WTK seeks shareholders’ approval for RM555mil plantation acquisitions

Trending in Business

Others Also Read

Load more

Copyright © 1995- Star Media Group Berhad [197101000523 (10894-D)]

Best viewed on Chrome browsers.